Literature DB >> 27818773

Transurethral biopsy of the prostatic urethra is associated with final apical margin status at radical cystoprostatectomy.

Friedrich-Carl von Rundstedt1, Douglas A Mata2, Steven Shen3, Yi Li4, Guilherme Godoy4, Seth P Lerner4.   

Abstract

PURPOSE: Biopsy of the prostatic urethra is an integral part of clinical staging in patients prior to radical cystoprostatectomy (RC) and urinary diversion. We examined whether preoperative transurethral resection (TUR) biopsy was associated with final apical urethral margin status and hypothesized that a negative biopsy could replace intraoperative frozen section for decision making regarding the feasibility of orthotopic neobladder reconstruction.
METHODS: TUR biopsy, frozen section, urethrectomy, and final apical urethral margin pathologic data were extracted from the charts of men who had undergone RC at the Houston Methodist Hospital between 1987 and 2013. TUR biopsies were performed at five and seven o'clock adjacent to the verumontanum. A positive biopsy was defined as the presence of in situ or invasive urothelial carcinoma. Clinical and perioperative variables were analyzed using descriptive and inferential statistics.
RESULTS: We reviewed the medical records of 272 men. Preoperative TUR biopsies of the prostatic urethra were negative in 74% (200/272) and positive in 26% (72/272) of men. The overall incidence of apical urethral margin positivity on final pathology was 2.2% (six of 272). Four men underwent primary or secondary urethrectomy. TUR biopsy negative and positive predictive values for apical urethral margin positivity were 99.5% (95% confidence interval (CI): 97.2 to 99.9) and 6.9% (95% CI: 2.3 to 15.5), respectively.
CONCLUSIONS: The incidence of a positive apical urethral margin was low in patients undergoing RC. A negative preoperative TUR biopsy of the prostatic urethra was reliably associated with a negative final margin, obviating the need for intraoperative frozen section. Furthermore, a positive biopsy was not reliably associated with final margin status. These data will aid in the counseling of patients regarding the feasibility of neobladder reconstruction.

Entities:  

Keywords:  Cystectomy; carcinoma in situ; prostate; transurethral biopsy; urothelial cancer

Year:  2016        PMID: 27818773      PMCID: PMC5096792          DOI: 10.1177/2051415815617876

Source DB:  PubMed          Journal:  J Clin Urol        ISSN: 2051-4158


  12 in total

1.  Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis.

Authors:  P F Schellhammer; M A Bean; W F Whitmore
Journal:  J Urol       Date:  1977-09       Impact factor: 7.450

2.  Anatomic considerations in carcinoma of the prostate.

Authors:  T M Wheeler
Journal:  Urol Clin North Am       Date:  1989-11       Impact factor: 2.241

3.  Late recurrence after radical cystectomy: patterns, risk factors and outcomes.

Authors:  Brian J Linder; Stephen A Boorjian; Tvrtko Hudolin; John C Cheville; Prabin Thapa; Robert F Tarrell; Igor Frank
Journal:  J Urol       Date:  2013-12-10       Impact factor: 7.450

4.  Prostatic biopsy in selected patients with carcinoma in situ of the bladder: preliminary report.

Authors:  H Grabstald
Journal:  J Urol       Date:  1984-12       Impact factor: 7.450

5.  Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.

Authors:  D Esrig; J A Freeman; D A Elmajian; J P Stein; S C Chen; S Groshen; A Simoneau; E C Skinner; G Lieskovsky; S D Boyd; R J Cote; D G Skinner
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

6.  Prostatic involvement in bladder cancer. Prostate mapping in 20 cystoprostatectomy specimens.

Authors:  P S Mahadevia; L G Koss; I J Tar
Journal:  Cancer       Date:  1986-11-01       Impact factor: 6.860

Review 7.  The remnant urothelium after reconstructive bladder surgery.

Authors:  Arnulf Stenzl; Georg Bartsch; Hermann Rogatsch
Journal:  Eur Urol       Date:  2002-02       Impact factor: 20.096

8.  Prostatic urethral biopsy has limited usefulness in counseling patients regarding final urethral margin status during orthotopic neobladder reconstruction.

Authors:  Wassim Kassouf; Philippe E Spiess; Gordon A Brown; Ping Liu; H Barton Grossman; Colin P N Dinney; Ashish M Kamat
Journal:  J Urol       Date:  2008-05-15       Impact factor: 7.450

Review 9.  Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer.

Authors:  Seth P Lerner; Steven Shen
Journal:  Urol Oncol       Date:  2008 Sep-Oct       Impact factor: 3.498

10.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

Authors:  J Alfred Witjes; Eva Compérat; Nigel C Cowan; Maria De Santis; Georgios Gakis; Thierry Lebret; Maria J Ribal; Antoine G Van der Heijden; Amir Sherif
Journal:  Eur Urol       Date:  2013-12-12       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.